PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 4KRM

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	53.8	H1	13	H1-13-*	-1	AASGRTSRSYGMG	BBBEBAABBBBBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	40.0	H2	10	H2-10-2	10	GISWRGDSTG	BBBAALABBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H3	17	H3-17-*	-1	AAAAGsawYGTLYEYDY
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H4	8	H4-8-1	13	RDNAKNTV	BBAAALBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	53.8	H1	13	H1-13-*	-1	AASGRTSRSYGMG	BBBEBABBBBBBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	40.0	H2	10	H2-10-2	14	GISWRGDSTG	BBBAALABBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H3	17	H3-17-*	-1	AAAAGsawYGTLYEYDY
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H4	8	H4-8-1	11	RDNAKNTV	BBAAALBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	53.8	H1	13	H1-13-*	-1	AASGRTSRSYGMG	BBBEBABBBBBBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	40.0	H2	10	H2-10-2	8	GISWRGDSTG	BBBAALABBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H3	17	H3-17-*	-1	AAAAGsawYGTLYEYDY
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H4	8	H4-8-1	14	RDNAKNTV	BBAAALBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	53.8	H1	13	H1-13-*	-1	AASGRTSRSYGMG	BBBEBABBBBBBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	40.0	H2	10	H2-10-2	13	GISWRGDSTG	BBBAALABBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H3	17	H3-17-*	-1	AAAAGsawYGTLYEYDY
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H4	8	H4-8-1	13	RDNAKNTV	BBAAALBB
J	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	53.8	H1	13	H1-13-*	-1	AASGRTSRSYGMG	BBBEBAABBBBBB
J	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	40.0	H2	10	H2-10-2	12	GISWRGDSTG	BBBAALABBB
J	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H3	17	H3-17-*	-1	AAAAGsawYGTLYEYDY
J	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H4	8	H4-8-1	10	RDNAKNTV	BBAAALBB
L	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	53.8	H1	13	H1-13-*	-1	AASGRTSRSYGMG	BBBEBABBBBBBB
L	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	40.0	H2	10	H2-10-2	10	GISWRGDSTG	BBBAALABBB
L	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H3	17	H3-17-*	-1	AAAAGsawYGTLYEYDY
L	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	100.0	H4	8	H4-8-1	14	RDNAKNTV	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022